Fresenius (NYSE:FMS) business group Fresenius Kabi said today that it plans to invest more than $100 million over the next five years in a Wilson, N.C.-based manufacturing site. The company’s expansion project is designed to boost the facility’s capacity to produce generic medicines in pre-filled syringes, Fresenius reported. Get the full story at our sister site, Drug Delivery […]
Medtech imaging developer Modulated Imaging said today it closed a $2.9 million Series A financing round that was joined by dialysis giant Fresenius Medical Care‘s (NYSE:FMS; ETR:FRE) Ventures arm. The round was led by Grey Sky Venture Partners and joined by Mitsubishi UFJ Capital, Fresenius Medical Care Ventures and Hamamatsu Photonics’ Photonics Management Corporation, the […]
Shares in Fresenius Medical Care (NYSE:FMS; ETR:FRE) have fallen slightly today after the dialysis-focused medical device company missed sales expectations on Wall Street with its 3rd quarter earnings results, despite topping EPS results. The Bad Homburg, Germany-based company posted profits of $359.9 million, or $1.18 per share, on sales of $5.1 billion for the 3 months […]
Fresenius Medical Care (NYSE:FMS; ETR:FRE) and NxStage Medical (NSDQ:NXTM) have received a request from the US Federal Trade Commission asking for more information on Fresenius’ $2 billion acquisition of NxStage, according to an SEC filing. The companies originally announced the acquisition in August, with Fresenius looking to pay $30 per share for Lawrence, Mass.-based home hemodialysis developer […]
From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to […]
Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the largest […]
Fresenius Kabi said today that it closed its acquisition of Merck KGaA’s biosimilars unit. The company paid €156 million at closing ($185.7 million USD) and could pay up to €500 million ($595.2 million USD) in milestone payments, which are contingent upon meeting certain drug development targets. Get the full story at our sister site, Drug Delivery Business News.
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said today that it agreed to pay $2 billion to acquire NxStage Medical (NSDQ:NXTM) and the home hemodialysis technology it developed. The $30-per-share deal, which is expected to close this year, represents a 29.6% premium on the August 4 closing price of $23.14 for NXTM shares. The stock was up 25.5% […]
Akorn Inc. (NSDQ:AKRX) shareholders voted yesterday to approve its $4.75 billion merger deal with German healthcare company Fresenius (ETR:FRE). Fresenius’ Kabi division announced in April that it inked a deal to acquire the generic drugmaker, bringing with it a portfolio of ophthalmic drugs, ear drops, nasal sprays, respiratory drugs and medical creams. Get the full story at our sister site, Drug Delivery Business News.
Fresenius Medical Care (ETR:FRE) said it will look to grow its revenue to $26.9 billion (EU €24 billion) by 2020, as well as the launch of a global efficiency program looking to reduce spending. The company made the announcement during its capital markets day in Frankfort this week. Fresenius said that the goal of $26.9 billion represents […]
Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis in a nearly $4 million insider trading scheme, federal prosecutors and the U.S. Securities & Exchange Commission alleged today. An SEC lawsuit and a criminal complaint accuse political consultant David Blaszczak, founder of Precipio Health Strategies […]